Ventus Therapeutics procures $100m in Series B round

Waltham, Massachusetts and Montreal-based biotechnology company Ventus Therapeutics has raised $100 million in a Series B financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this